DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Nasrallah M, Pouliot Y, Hartmann B. et al.
Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment.
Arthritis Res Ther 2015;
17: 262
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.